Virginia Tech® home
Wenyan Ji

Wenyan Ji earned her MA degree in Biostatistics from the SUNY University at Buffalo (UB) (2018). She then worked for Roswell Comprehensive Cancer Center for three years as a biostatistician. She worked with Department of Urology and Surgical Oncology in pre-clinical, clinical and translational studies for a variety of disease settings and outcomes, including but not limited to cardiovascular disease, breast cancer, prostate cancer, gastric cancer, leukemia, Covid-19 related disease, opioid use, healthy lifestyle and tobacco use, where she provided support in methodologies developments, statistical analysis and manuscripts and proposals preparations. She is now working for Center for Biostatistics & Health Data Science (CBHDS) as a research associate. She has authored/co-authored over 40 peer-reviewed scientific publications.

Kathy C Richards, Alicia J Lozano, Jennifer Morris, Stephen T Moelter, Wenyan Ji, Vani Vallabhaneni, Yanyan Wang, Luqi Chi, Eric M Davis, Cindy Cheng, Vanessa Aguilar, Sneha Khan, Mira Sankhavaram, Alexandra L Hanlon, David A Wolk, Nalaka Gooneratne (2023). Predictors of Adherence to Continuous Positive Airway Pressure in Older Adults With Apnea and Amnestic Mild Cognitive Impairment. The Journals of Gerontology, 78(10), 1861-1870.

Rajesh Kunadharaju MD, Arjun Saradna MD, Andrew Ray PT, PhD, Han Yu PhD, MBBS, Wenyan Ji MA, Michelle Zafron MLS, Martin Jeffery Mador MD (2023). Post-Operative Outcomes of Pre-Thoracic Surgery Respiratory Muscle Training vs Aerobic Exercise Training: A Systematic Review and Network Meta-analysis. Archives of Physical Medicine and Rehabilitation, 104(5), 790-798.

Seo Hyun Kim, MD, Anna Buhle, MD, Abra Roberts, MD, Neha Singh, BS, Adil Mir, MD, Varun Kesar, MD, Alicia Lozano, MS, Wenyan Ji, MA, Alexandra Hanlon, MS, Ph.D, Douglas Grider, MD (2023). Multidisciplinary Inflammatory Bowel Disease Conference: The Impact of the Expert Pathologist on Patient Care. Inflammatory Bowel Disease.

Arielle Brackett, Elizabeth McCarthy, Wenyan Ji, Alexandra Hanlon, Robin Ellis, John Getchell, Caitlin Halbert (2023). Safety and feasibility of destination care for bariatric surgery: a single institution retrospective study. Surgical Endoscopy, 37(12):9609-9616.

Amanda C Przespolewski, Joseph R Hanson, Wenyan Ji, Tara Cronin, Joseph D Tario Jr, Eunice S Wang (2023). Increased Monocytic Myeloid-Derived Suppressor Cells Are Associated with Inferior Overall Survival in Patients with Newly Diagnosed Acute Myeloid Leukemia. Blood, 142, 6023.

Hassan Awada, Manasa Bhatta, Han Yu, Wenyan Ji, Surui Hou, Tara Cronin, Sheeba Ba Aqeel, Arya Mariam Roy, Muhammad Salman Faisal, Peter Kouides, John Mascarenhas, Elizabeth A Griffiths, Amro Elshoury (2023). ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms. Leukemia, 1-5.

Emese Zsiros, Jason Ricciuti, Steven Gallo, Deanna Argentieri, Kristopher Attwood, Wenyan Ji, Alan Hutson, Paul Visco, Devon Coffey, Grazyna Riebandt, Jaron Mark, Aaron Varghese, Suzanne M Hess, Thomas Furlani, Andrew Fabiano, Mark Hennon, Sai Yendamuri, Eric C Kauffman, Kimberly E Wooten, Wesley L Hicks, Jessica Young, Kazuaki Takabe, Kunle Odunsi, Amy A Case, Brahm H Segal, Candace S Johnson, Boris Kuvshinoff, Steven Nurkin, Gyorgy Paragh, Oscar de Leon-Casasola (2023). Postoperative Restrictive Opioid Protocols Resulted in Durable Changes in Opioid Prescribing and Reduced Chronic Opioid Use. JAMA Oncology, 9(2), 234-241.

Khoury, T., Aljabab, S., Yao, S., Ambrosone, C., Omilian, A., Attwood, K., Ji, W., Gandhi, S. (2022). Tumor-associated mononuclear cells in the tumor bed of triple-negative breast cancer associate with clinical outcomes in the post-neoadjuvant chemotherapy setting. Breast Cancer Research and Treatment, 194(3), 531-540.

Mazen Jizzini, Othman Salim Akhtar, Kris Atwood, Wenyan Ji, Jordan Pleskow, Taha Bat, Sophia Balderman (2022). Anti-Xa based dosing of enoxaparin in hematopoietic stem cell transplant and adoptive cell therapy patients: A single center experience. Thrombosis Research, 211, 6-9.

Emam, A., Hermann, G., Attwood, K., Ji, W., James, G., Kuettel, M., & Mohler, J. (2021). Oncologic outcome of radical prostatectomy versus radiotherapy as primary treatment for high and very high risk localized prostate cancer. The Prostate, 81(4), 223–230.

Kunadharaju, R., Saradna, A., Ray, A., Yu, H., Ji, W., Zafron, M., & Mador, M.J. (2022).Post-Operative Outcomes of Pre-Thoracic Surgery Respiratory Muscle Training Vs. Aerobic Exercise Training: A Systematic Review and Network Meta-analysis. Archives of physical medicine and rehabilitation, S0003-9993(22)01728-2

Khoury, T., Aljabab, S., Yao, S., Ambrosone, C., Omilian,  A., Attwood, K., Ji, W., Gandhi, S. (2022). Tumor- associated mononuclear cells in the tumor bed of triple-negative breast cancer associate with clinical outcomes in the post-neoadjuvant chemotherapy setting. Breast Cancer Research and Treatment, 194(3), 531- 540

Gandhi, S. , Attwood, K., Ji, W., Aljabab, S., & Khoury, T. (2022). Abstract P4-06 04: Theroleofaxillarylymph node status in residual cancer burden calculation of triple negative breast cancer post-neoadjuvant cytotoxic chemotherapy. Cancer Research, 82(4_Supplement)

Emese Zsiros, Jason Ricciuti, Steven Gallo, Deanna Argentieri, Kristopher Attwood, Wenyan Ji, Alan Hutson,  Paul Visco, Devon Coffey, Grazyna Riebandt, Jaron Mark, Aaron Varghese, Suzanne M Hess, Thomas Furlani, Andrew Fabiano, Mark Hennon, Sai Yendamuri, Eric C Kauffman, Kimberly E Wooten, Wesley L Hicks, Jessica Young, Kazuaki Takabe, Kunle Odunsi, Amy A Case, Brahm H Segal, Candace S Johnson, Boris Kuvshinoff, Steven Nurkin, Gyorgy Paragh, Oscar de Leon-Casasola (2023). Postoperative Restrictive Opioid Protocols Resulted in Durable Changes in Opioid Prescribing and Reduced Chronic Opioid Use. JAMA Oncology. 

Amro Elshoury, Han Yu, Wenyan Ji, James E Thompson, Elizabeth A Griffiths, Amanda Przespolewski, Steven Daniel Green, Pamela J Sung, Hassan Awada, Eunice S Wang, Peter A Kouides (2021). ASXL1 Mutation Is a Novel Risk Factor for Bleeding in Patients with Philadelphia-Negative Myeloproliferative Neoplasms (MPN). Blood, 138, 3637

Jason Ricciuti, Aaron Varghese, Steven Gallo, Deanna Argentieri, Wenyan Ji, Alan Hutson, Jaron Mark, Emese Zsiros (2021). Using restrictive opioid protocols for postsurgical pain management does not compromise patient reported outcomes. Gynecologic Oncology, 162, S325-S326.

Emam, A., Hermann, G., Attwood, K., Ji, W., James, G., Kuettel, M., & Mohler, J. (2021). Oncologic outcome of radical  prostatectomy  versus  radiotherapy  as  primary  treatment  for  high  and  very  high  risk  localized prostate cancer. The Prostate, 81(4), 223–230.

Gupta, M., Gosain, R., Sarma, M., Perimbeti, S., Attwood, K., Ji,  W., Gandhi, S., & Abdou, Y. (2021). Abstract   PS7-29: Racial disparities in breast cancer outcomes: A SEER population based study. Cancer Research, 81(4 Supplement), PS7-29-PS7-29.

Przespolewski, A., Muppidi, M., Freyer, C., Ji, W., Cronin, T., Thota, S., Griffiths, E., Thompson, J., Ontiveros, E., Baron, J., & others (2021). Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with  adverse  karyotype  and  prior  hypomethylating  therapy. Leukemia & Lymphoma, 1–6.

Gabriel, E., Kim, M., Fisher, D., Mangum, C., Attwood, K., Ji, W., Mukhopadhyay, D., Bagaria, S., Robertson, M., Dinh, T., & others (2021). A pilot trial of intravital microscopy  in  the  study  of  the  tumor  vasculature  of  patients with peritoneal carcinomatosis. Scientific reports, 11(1), 1–13.

Mangum, C., Kim, M., Fisher, D., Attwood, K., Ji, W., Mukhopadhyay, D., Bagaria, S., Robertson, M., Dinh, T., Knutson, K., & others (2021). Intravital Mroscopy in  the  Study  of  the  Tumor  Vasculature  of  Patients  with  Peritoneal Carcinomatosis. ANNALS OF SURGICAL ONCOLOGY, 28(SUPPL 1), S115-S115.

Farrugia, M., Erickson, K., Wendel, E., Platek, M., Ji, W., Attwood, K., Ma, S., Gu, F., Singh, A., & Ray, A. (2021). Change in Physical Performance Correlates with Decline in Quality of Life and Frailty Status in Head and Neck Cancer Patients Undergoing Radiation with and without Chemotherapy. Cancers, 13(7), 1638.

Ricciuti, J., Gallo, S., Argentieri, D., Visco, P., Attwood, K., Ji, W., Fabiano, A., Hennon, M., Kauffman, E., Wooten, K., & others (2021). Less is more: Postoperative pain management using restrictive  opioid  protocols  in  all surgical services in a comprehensive cancer center. Journal of Clinical Oncology, 39(15_suppl), 103-103.

Gandhi, S., Pandey, M., Attwood, K., Ji, W., Witkiewicz, A., Knudsen, E., Allen, C., Tario, J., Wallace, P., Cedeno, C., & others (2021). Phase I clinical trial of combination propranolol and pembrolizumab in locally advanced and metastatic melanoma: safety, tolerability, and preliminary evidence of antitumor activity. Clinical  Cancer Research, 27(1), 87–95.

Trumbull, D., Lemini, R., Vico, T., Jorgensen, M., Attwood, K., Ji, W., Brady, M., Gabriel, E., & Kukar, M. (2021). Prognostic significance of complete  pathologic  response  obtained  with  chemotherapy  versus  chemoradiotherapy in gastric cancer. Annals of Surgical Oncology, 28(2), 766–773.

Peng, J., Brady, M., Ji, W., Attwood, K., Kukar, M., & Hochwald, S. (2020). Is the National Surgical Quality Improvement  Program  Calculator  Predictive  of  Outcomes  After  Minimally  Invasive  Esophagectomy?.  ANNALS  OF SURGICAL ONCOLOGY, 27(SUPPL 1), S166-S166.

Peng, J., Brady, M., Ji, W., Attwood, K., Hochwald, S., & Kukar, M. (2020). Predictors of Early Recurrence After Resection for Esophageal and Gastroesophageal Junction Cancer. ANNALS OF SURGICAL ONCOLOGY, 27(SUPPL 1), S185-S185.

Peng, J., Brady, M., Ji, W., Attwood, K., Hochwald, S., & Kukar, M. (2020). Impact of Smoking  Status  on Postoperative  and  Oncologic  Outcomes  After  Esophagectomy  for  Gastroesophageal  Junction  Cancer.   ANNALS   OF SURGICAL ONCOLOGY, 27(SUPPL 1), S166-S167.

Hanif, A., Khan, S., Mantri, N., Hanif, S., Saleh, M., Alla, Y., Chinta, S., Shrestha, N., Ji, W., Attwood, K., & others (2020). Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience. Annals of hematology, 99(10), 2323–2328.

Gupta, M., Gosain, R., Sarma, M., Perimbeti, S., Kristopher, A., Ji, W., Gandhi, S., & Abdou, Y. (2020). Abstract PO-221: Racial disparities in breast cancer  characteristics  and  outcomes  among  Hispanic  and  White  patients.  Cancer Epidemiology and Prevention Biomarkers, 29(12 Supplement), PO-221-PO-221.

Abdou, Y., Elkhanany, A., Attwood, K., Ji, W., Takabe, K., & Opyrchal, M. (2019). Primary and secondary breast angiosarcoma: single center report and a meta-analysis. Breast  cancer  research  and  treatment,  178(3),  523– 533.

Przespolewski, A., Freyer, C., Ji, W., Cronin, T., Thota, S., Griffiths, E., Thompson,  J.,  Elshoury,  A.,  Baron,  J., Walsh, M., & others. (2019).  Cladribine,  Cytarabine,  Granulocyte  Colony  Stimulating  Factor  ±  Mitoxantrone  (CLAG ± M) Is Highly  Effective  Therapy  for  Secondary  and  Relapsed/Refractory  Acute  Myeloid  Leukemia.  Blood, The Journal of the American Society of Hematology, 134(Supplement_1), 1361-1361.

Lone*, Z., Khan, H., Steele, M., Bizovi, J., Elsayed, A., Aldhaam, N., Hussein, A., Ji, W., Attwood, K., Davidson, R., & others (2019). PD63-11 ART HEALS: DOES ART THERAPY HELP IN THE RECOVERY OF PATIENTS AFTER MAJOR ONCOLOGIC SURGERY?. The Journal of Urology, 201(Supplement 4), e1116–e1116.

Lemini, R., Attwood, K., Almerey, T., Gunn, J., Yeager, T., Elias, A., Partain, K., Jorgensen, M., Ji, W., Gabriel, E., & others (2019). Is metastasectomy a worthy  option?—the  role  of  surgery  in  metastatic  colon  cancer  to  liver  and lungs. Journal of gastrointestinal oncology, 10(6), 1032.

Yeager, T., Partain, K., Gunn, J., Almerey, T., Lemini, R., Ji, W., Attwood, K., Bagaria, S., & Gabriel, E. (2019). The Prognostic Significance of the Lymph Node Ratio in Gastric Neuroendocrine Tumors. ANNALS OF SURGICAL ONCOLOGY, 26, S130–S130.

Terhune, J., Fisher, D., Khushalani, N., Ji, W., Attwood, K., & Skitzki, J. (2019). Identification of Immunotherapy Targets After IL-2 Treatment. ANNALS OF SURGICAL ONCOLOGY, 26, S162–S163.

Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017). Leveraging physiology for precision drug delivery. Physiological reviews, 97(1), 189–225.

Sun, W., Ji, W., Hu, Q., Yu, J., Wang, C., Qian, C., Hochu, G., & Gu, Z. (2016). Transformable DNA nanocarriers for plasma membrane targeted delivery of cytokine. Biomaterials, 96, 1–10.

Ji, W., Sun, W., Feng, J., Song, T., Zhang, D., Ouyang, P., Gu, Z., & Xie, J. (2015). Characterization of a novel N-acetylneuraminic  acid  lyase   favoring   industrial   N-acetylneuraminic   acid   synthesis   process.   Scientific   reports, 5(1), 1–9.

Sun, W., Ji, W., Hall, J., Hu, Q., Wang, C., Beisel, C., & Gu, Z. (2015). Titelbild: Self-Assembled DNA Nanoclews for the  Efficient   Delivery   of   CRISPR–Cas9   for   Genome   Editing   (Angew.   Chem.   41/2015).   Angewandte  Chemie, 127(41), 12045–12045.

Sun, W., Ji,  W., Hall, J., Hu, Q., Wang, C., Beisel, C., & Gu, Z. (2015). Self-assembled DNA nanoclews for the  efficient delivery of CRISPR–Cas9 for genome editing. Angewandte Chemie, 127(41), 12197–12201.

Sun, W., Ji,  W., Hall, J., Hu, Q., Wang, C., Beisel, C., & Gu, Z. (2015). CRISPR–Cas9 Delivery by DNA Nanoclews  for Efficient Genome Editing. MRS/ASM/AVS 2015, 51.

Sun, W., Ji, W., Hall, J., Hu, Q., Wang, C., Beisel, C., & Gu, Z. (2015). Efficient delivery of CRISPR-Cas9 for genome editing via self-assembled DNA nanoclews. Angewandte Chemie (International ed. in English), 54(41), 12029.

Sun, W., Ji, W., Hall, J., Hu, Q., Wang, C., Beisel, C., & Gu, Z. (2015). Cover Picture: Self-Assembled DNA Nanoclews for the Efficient Delivery of CRISPR–Cas9 for Genome Editing (Angew. Chem. Int. Ed. 41/2015). Angewandte Chemie International Edition, 54(41), 11877–11877.

Sun, W., Ji, W., Li, N., Tong, P., Cheng, J., He, Y., Chen, Y., Chen, X., Wu, J., Ouyang, P., & others (2013). Construction and expression of a polycistronic plasmid encoding N-acetylglucosamine 2-epimerase and N-acetylneuraminic acid lyase simultaneously for production of N-acetylneuraminic  acid.  Bioresource  technology, 130, 23–29.